Pharmacie Delaunoy SRL
2.1 FTEPharmacie Delaunoy reported total assets of 522,244 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026), with 2.1 full-time equivalents.
The score of Pharmacie Delaunoy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Delaunoy's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
Pharmacie Delaunoy's financial analysis
- Solvency16.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Delaunoy
Pharmacie Delaunoy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1008.127.037
- VAT number
- BE1008127037
- Peppol
- Registered · 0208:1008127037 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Apr 2024
- Registered office
- 1080 Molenbeek-Saint-Jean
- Size
- Micro · 2.1 FTE
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Delaunoy (SRL) has been based in Molenbeek-Saint-Jean since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 155,709 € and equity of 85,243 €; its revenue is not published. With 2.1 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Delaunoy
Companies in the same business, of comparable size and area, outside its group.
- Les Pharmacies Lambrechts Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 896,725 €
- Apotheek De Vijzel Retail sale of pharmaceutical products Zoersel · balance sheet 509,493 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- LNR Retail sale of pharmaceutical products Kasterlee · balance sheet 516,544 €
- P.J. VLEUGELS et Cie Retail sale of pharmaceutical products Frameries · balance sheet 558,880 €
- ML Pharma Retail sale of pharmaceutical products Brussels · balance sheet 573,903 €
- Medicuro Retail sale of pharmaceutical products Stekene · balance sheet 457,159 €
- Smets Pharma Retail sale of pharmaceutical products Lier · balance sheet 452,862 €
Frequently asked questions about Pharmacie Delaunoy
What is the revenue of Pharmacie Delaunoy?
Pharmacie Delaunoy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Delaunoy?
In Belgium, the VAT number is the company number prefixed with BE: BE1008127037 for Pharmacie Delaunoy, if the company is VAT-registered. Its company number (CBE) is 1008.127.037.
Where is the registered office of Pharmacie Delaunoy?
According to the CBE register, the registered office of Pharmacie Delaunoy is in 1080 Molenbeek-Saint-Jean.
What is the equity of Pharmacie Delaunoy?
At the close of the 2025 financial year, the equity of Pharmacie Delaunoy amounts to 85,243 €, a solvency of 16.3% of total assets.
How many people work at Pharmacie Delaunoy?
2.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmacie Delaunoy?
The register lists 1 active mandates at Pharmacie Delaunoy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Delaunoy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →